Immuneering Corp. (IMRX)
6.235
-0.28
(-4.37%)
USD |
NASDAQ |
Dec 09, 16:00
6.35
+0.12
(+1.84%)
After-Hours: 20:00
Immuneering Total Liabilities (Quarterly): 13.08M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Fortress Biotech, Inc. | 116.22M |
| BridgeBio Pharma, Inc. | 2.921B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 241.06M |
| Shareholders Equity (Quarterly) | 227.98M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 24.00 |
| Net Debt Paydown Yield | 0.02% |